US 11623010
Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment
granted A61KA61K31/4375A61K31/56
Quick answer
US patent 11623010 (Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment) held by BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD.
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4375, A61K31/56, A61K31/575, A61K47/44